NSE:EMCURE

1 story mentioning NSE:EMCUREUpdated 51d ago

Every FINWIRES story that references NSE:EMCURE, newest first.

Jefferies Adjusts Emcure Pharmaceuticals' Price Target to INR1,970 From INR1,780, Keeps at Buy

Emcure Pharmaceuticals (NSE:EMCURE, BOM:544210) has an average rating of buy and mean price target of 1,837.33 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:544210NSE:EMCURE

Track with the FINWIRES app suite

FolioX

Track NSE:EMCURE in your portfolio

WheelAI

Analyze NSE:EMCURE options with the wheel strategy

StockInsider

See market sentiment on NSE:EMCURE